Does the tumor localization in advanced pancreatic cancer have an influence on the management of symptoms and pain?
We believe that pancreatic cancer should be accepted as two diverse disease types according to tumor localization, and pain and symptom management should be organized based on this fact.
Bortezomib/ PLD/dexamethasone combination is safe and effective in elderly patients with resistant-relapsing MM.